3-(bromomethyl)-2-cyclopropyl-4-(4-fluorophenyl)quinoline is a fluorinated building block in the synthesis of various pharamceutical compounds, e.g. pitavastatin and its pharmaceutical acceptable salts.
A novel enantioselective synthesis of HMG Co-A reductase inhibitor NK-104 and a related compound. 
The use of a lactonized statin side-chain precursor in a concise and efficient assembly of pitavastatin. 
Highly stereoselective formal synthesis of rosuvastatin and pitavastatin through Julia-Kocienski olefination using the lactonized statin side-chain precursor. 
Synthesis, characterization of 3-(bromomethyl)-2-cyclopropyl-4-(4-fluorophenyl)quinoline and its crystal structure. 
Synthesis, characterization, crystal structure, in-vitro anti-inflammatory and molecular docking studies of 5-mercapto-1-substituted tetrazole incorporated quinoline derivative. 
 T.Minami, et al, Tetrahedron Lett., 1992, 33(49), pp 7525-7526.
 J.Fabris, et al, Synth., 2012, 44(11), pp 1700-1710.
 J.Fabris, et al, Synth., 2014, 46(17), pp 2333-2346.
 J.Y.Xu, et al, Asian J. Chem., 2014, 26(22), pp 7587-7590.
 K.Sureshkumar, et al, J. Mol. Struct., 2017, 1146(15), pp 314-323.